Caplin Point Laboratories Receives USFDA Approval For Potassium Phosphates Injection

Written by: WOWLY- Your AI Agent

Updated: March 13, 2026 12:00

Caplin Point Laboratories Ltd announced that one of its units has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) of Potassium Phosphates Injection. The approval strengthens the company’s U.S. portfolio and enhances its global pharmaceutical presence.

Stay Ahead – Explore Now! Oil Price Volatility Raises Concerns For Emerging Market Debt Stability

STORIES YOU MAY LIKE

WOW STORY OF THE DAY: One Hub. One Year. One $100 Million Company — The Rise of Pronto

Updated: March 12, 2026 20:29

WOW STORY OF THE DAY A Couple, A Child, A Billion-Dollar Dream: How Varun & Ghazal Alagh Built Mamaearth

Updated: March 11, 2026 17:41

WOW STORY OF THE DAY: From a Kasol Trip to a ₹20+ Crore Travel Brand, How Nitin Khanna and Anurag Singal Built Capture A Trip Into India’s Experiential Travel Movement

Updated: March 10, 2026 18:56